DGX Quest Diagnostics IncorporatedFinancial Income Statement
$138.420.26 (+0.19%)4:00 PM 05/10/24
NYSE | $USD | Post-Market: $138.42 7:00 PM
DGX Income Statement
Period
View
Order
Currency
Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | TTM | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | ||||||||||||
| Revenues | 7,726.0 | 9,437.0 | 10,788.0 | 9,883.0 | 9,252.0 | 9,287.0 | ||||||
| Other Revenues | - | - | - | - | - | - | ||||||
| Total Revenues | 7,726.0 | 9,437.0 | 10,788.0 | 9,883.0 | 9,252.0 | 9,287.0 | ||||||
| Cost Of Revenues | 5,037.0 | 5,795.0 | 6,571.0 | 6,418.0 | 6,183.0 | 6,215.0 | ||||||
| Gross Profit | 2,689.0 | 3,642.0 | 4,217.0 | 3,465.0 | 3,069.0 | 3,072.0 | ||||||
Operating Expenses & Income | ||||||||||||
| Selling General & Admin Expenses | 1,457.0 | 1,545.0 | 1,723.0 | 1,818.0 | 1,615.0 | 1,621.0 | ||||||
| Other Operating Expense/(Income) | (16.0) | 6.0 | (2.0) | (22.0) | 12.0 | 13.0 | ||||||
| Total Operating Expenses | 1,537.0 | 1,654.0 | 1,824.0 | 1,916.0 | 1,735.0 | 1,745.0 | ||||||
| Operating Income | 1,152.0 | 1,988.0 | 2,393.0 | 1,549.0 | 1,334.0 | 1,327.0 | ||||||
Earnings from Continuing Operations | ||||||||||||
| Interest Expense | (180.0) | (166.0) | (152.0) | (148.0) | (163.0) | (175.0) | ||||||
| Interest And Investment Income | 5.0 | 3.0 | 1.0 | 10.0 | 11.0 | 15.0 | ||||||
| Net Interest Expenses | (175.0) | (163.0) | (151.0) | (138.0) | (152.0) | (160.0) | ||||||
| Other Non Operating Income (Expenses) | 20.0 | 76.0 | 55.0 | (25.0) | 20.0 | 22.0 | ||||||
| EBT, Incl. Unusual Items | 1,133.0 | 1,959.0 | 2,677.0 | 1,279.0 | 1,156.0 | 1,148.0 | ||||||
| Income Tax Expense | 247.0 | 460.0 | 597.0 | 264.0 | 248.0 | 249.0 | ||||||
| Earnings From Continuing Operations | 886.0 | 1,499.0 | 2,080.0 | 1,015.0 | 908.0 | 899.0 | ||||||
Net Income | ||||||||||||
| Earnings Of Discontinued Operations | 20.0 | - | - | - | - | - | ||||||
| Net Income to Company | 906.0 | 1,499.0 | 2,080.0 | 1,015.0 | 908.0 | 899.0 | ||||||
| Minority Interest | (48.0) | (68.0) | (85.0) | (69.0) | (54.0) | (53.0) | ||||||
| Net Income | 858.0 | 1,431.0 | 1,995.0 | 946.0 | 854.0 | 846.0 | ||||||
| Preferred Dividend and Other Adjustments | 3.0 | 6.0 | 7.0 | 4.0 | 4.0 | 4.0 | ||||||
| NI to Common Incl Extra Items | 855.0 | 1,425.0 | 1,988.0 | 942.0 | 850.0 | 842.0 | ||||||
| NI to Common Excl. Extra Items | 835.0 | 1,425.0 | 1,988.0 | 942.0 | 850.0 | 842.0 | ||||||
Supplemental Items | ||||||||||||
| Revenue Per Share | $57.66 | $70.43 | $86.30 | $85.20 | $82.61 | $83.11 | ||||||
| Basic EPS | $6.38 | $10.63 | $15.90 | $8.12 | $7.59 | $7.53 | ||||||
| Basic EPS - Continuing Ops | $6.23 | $10.63 | $15.90 | $8.12 | $7.59 | $7.53 | ||||||
| Basic Weighted Average Shares Outst. | 134.0 | 134.0 | 125.0 | 116.0 | 112.0 | 111.8 | ||||||
| Diluted EPS | $6.28 | $10.47 | $15.55 | $7.97 | $7.49 | $7.43 | ||||||
| Diluted EPS - Continuing Ops | $6.13 | $10.47 | $15.55 | $7.97 | $7.49 | $7.43 | ||||||
| Diluted Weighted Average Shares Outst. | 136.0 | 136.0 | 128.0 | 118.0 | 113.0 | 112.8 | ||||||
| Normalized Basic EPS | $4.56 | $8.71 | $11.20 | $7.11 | $6.37 | $6.34 | ||||||
| Normalized Diluted EPS | $4.49 | $8.58 | $10.93 | $6.99 | $6.31 | $6.28 | ||||||
| Dividend Per Share | $2.12 | $2.24 | $2.48 | $2.64 | $2.84 | $2.88 | ||||||
| Payout Ratio | 33.33% | 20.75% | 15.49% | 32.24% | 36.77% | 37.71% | ||||||
| EBITDA | 1,481.0 | 2,349.0 | 2,801.0 | 1,986.0 | 1,773.0 | 1,775.0 | ||||||
| EBITA | 1,248.0 | 2,091.0 | 2,496.0 | 1,669.0 | 1,442.0 | 1,438.0 | ||||||
| EBIT | 1,152.0 | 1,988.0 | 2,393.0 | 1,549.0 | 1,334.0 | 1,327.0 | ||||||
| EBITDAR | 1,775.0 | 2,649.0 | 3,122.0 | 2,331.0 | 2,126.0 | - | ||||||
| Effective Tax Rate | 21.8% | 23.5% | 22.3% | 20.6% | 21.5% | 21.7% | ||||||
| Normalized Net Income | 610.8 | 1,167.0 | 1,399.4 | 824.8 | 713.5 | 708.3 | ||||||
| Interest on Long-Term Debt | 180.0 | 166.0 | 152.0 | 148.0 | 163.0 | - | ||||||
In Millions of United States Dollar (USD) except per share items